Profile
Noga Yerushalmi is currently Investment Director at Merck Ventures since 2017, Director at Metabomed Ltd., and Investment Director at Merck Ventures BV.
Formerly, Dr. Yerushalmi was Director at Pantheon Biosciences Ltd. Education includes an undergraduate degree (1989) and a doctorate (1996) from Tel-Aviv University.
Noga Yerushalmi active positions
| Companies | Position | Start |
|---|---|---|
Metabomed Ltd.
Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Director/Board Member | - |
Merck Ventures BV
Merck Ventures BV Investment ManagersFinance Merck Ventures invests in companies located in the Netherlands. The firm targets companies operating in the fields of healthcare, healthcare drug development, life science tools, electronics and frontier technology & sustainability sectors. It provides financing for early stage capital requirements. | Private Equity Investor | - |
Former positions of Noga Yerushalmi
| Companies | Position | End |
|---|---|---|
Pantheon Biosciences Ltd.
Pantheon Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Develops molecular therapies and tools | Director/Board Member | - |
Training of Noga Yerushalmi
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Metabomed Ltd.
Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Health Technology |
Merck Ventures BV
Merck Ventures BV Investment ManagersFinance Merck Ventures invests in companies located in the Netherlands. The firm targets companies operating in the fields of healthcare, healthcare drug development, life science tools, electronics and frontier technology & sustainability sectors. It provides financing for early stage capital requirements. | Finance |
Pantheon Biosciences Ltd.
Pantheon Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Develops molecular therapies and tools | Commercial Services |
- Stock Market
- Insiders
- Noga Yerushalmi
















